ST VINCENTS INSTITUTE OF MEDICAL RES has a total of 12 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Australia, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SILER-KHODR THERESA M, CDG THERAPEUTICS INC and CANCER ADVANCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Enzymes | |
#6 | Microorganisms | |
#7 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Miles Luke Anthony | 4 |
#2 | Parker Michael William | 3 |
#3 | Krishnamurthy Balasubramanian | 3 |
#4 | Jhala Gaurang | 3 |
#5 | Kay Thomas W H | 3 |
#6 | Thomas Helen E | 3 |
#7 | Nero Tracy Leah | 3 |
#8 | Kay Brian K | 1 |
#9 | Thomas Helen | 1 |
#10 | So Michelle | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019169448A1 | Multi-specific antibodies | |
WO2019104391A1 | Type 1 diabetes treatment | |
US2020345815A1 | Type i diabetes therapy | |
US2016194385A1 | Antibody therapy for amyloid beta disease | |
AU2003283116A1 | Method for the detection of newly acquired hiv infection | |
AU1500800A | Regulation of nitric oxide synthase activity |